LivaNova (LIVN)
(Delayed Data from NSDQ)
$51.43 USD
-0.99 (-1.89%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $51.57 +0.14 (0.27%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth A Momentum A VGM
Price, Consensus and EPS Surprise
LIVN 51.43 -0.99(-1.89%)
Will LIVN be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for LIVN based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for LIVN
LivaNova (LIVN) Q1 Earnings and Revenues Top Estimates
Earnings Preview: Tandem Diabetes Care, Inc. (TNDM) Q1 Earnings Expected to Decline
LIVN: What are Zacks experts saying now?
Zacks Private Portfolio Services
LivaNova (LIVN) Earnings Expected to Grow: Should You Buy?
LivaNova (LIVN) Soars 12.5%: Is Further Upside Left in the Stock?
LivaNova (LIVN) Q4 Earnings and Revenues Top Estimates
Other News for LIVN
LivaNova to Announce Second-Quarter 2024 Results
Jefferies medical technology analyst holds analyst/industry conference call
LivaNova’s Annual Meeting Strengthens Shareholder Alignment
LivaNova: A Strong Buy Opportunity Amidst RECOVER Trial Developments
Analysts Are Bullish on These Healthcare Stocks: LivaNova (LIVN), BridgeBio Pharma (BBIO)